A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)
Conditions
- Adult T-cell Leukemia
- Lymphoma
Interventions
- DRUG: VCAP-AMP-VECP with G-CSF and intrathecal prophylaxis
- DRUG: biweekly-CHOP with G-CSF and intrathecal prophylaxis
Sponsor
Japan Clinical Oncology Group
Collaborators